76 related articles for article (PubMed ID: 28841798)
1. Re-irradiation for recurrent glioblastoma multiforme.
Barney C; Shukla G; Bhamidipati D; Palmer JD
Chin Clin Oncol; 2017 Aug; 6(4):36. PubMed ID: 28841798
[TBL] [Abstract][Full Text] [Related]
2. Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence.
Cuccia F; Jafari F; D'Alessandro S; Carruba G; Craparo G; Tringali G; Blasi L; Ferrera G
J Pers Med; 2024 May; 14(5):. PubMed ID: 38793120
[TBL] [Abstract][Full Text] [Related]
3. A valuable glioblastoma prognostic marker driven by radiosensitivity.
Randall J; Sachdev S
Neuro Oncol; 2024 Mar; 26(3):514-515. PubMed ID: 38262690
[No Abstract] [Full Text] [Related]
4. Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
Scoccianti S; Francolini G; Carta GA; Greto D; Detti B; Simontacchi G; Visani L; Baki M; Poggesi L; Bonomo P; Mangoni M; Desideri I; Pallotta S; Livi L
Crit Rev Oncol Hematol; 2018 Jun; 126():80-91. PubMed ID: 29759570
[TBL] [Abstract][Full Text] [Related]
5. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F; Drappatz J; O'Rourke DM; Wong M; Hamilton MG; Finocchiaro G; Perry J; Wick W; Green J; He Y; Turner CD; Yellin MJ; Keler T; Davis TA; Stupp R; Sampson JH;
Lancet Oncol; 2017 Oct; 18(10):1373-1385. PubMed ID: 28844499
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.
Zhu JJ; Demireva P; Kanner AA; Pannullo S; Mehdorn M; Avgeropoulos N; Salmaggi A; Silvani A; Goldlust S; David C; Benouaich-Amiel A;
J Neurooncol; 2017 Dec; 135(3):545-552. PubMed ID: 28849310
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
[No Abstract] [Full Text] [Related]
9. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma targeted therapy: updated approaches from recent biological insights.
Touat M; Idbaih A; Sanson M; Ligon KL
Ann Oncol; 2017 Jul; 28(7):1457-1472. PubMed ID: 28863449
[TBL] [Abstract][Full Text] [Related]
11. A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers.
Straube C; Kessel KA; Zimmer C; Schmidt-Graf F; Schlegel J; Gempt J; Meyer B; Combs SE
Curr Treat Options Oncol; 2019 Jul; 20(9):71. PubMed ID: 31324990
[TBL] [Abstract][Full Text] [Related]
12. How We Treat Recurrent Glioblastoma Today and Current Evidence.
Chaul-Barbosa C; Marques DF
Curr Oncol Rep; 2019 Oct; 21(10):94. PubMed ID: 31606796
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation in the Brain: Primary Gliomas.
Ho ALK; Jena R
Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):124-136. PubMed ID: 29295736
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.
Møller S; Munck Af Rosenschöld P; Costa J; Law I; Poulsen HS; Engelholm SA; Engelholm S
Radiother Oncol; 2017 Nov; 125(2):223-227. PubMed ID: 29054380
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
Baehr A; Trog D; Oertel M; Welsch S; Kröger K; Grauer O; Haverkamp U; Eich HT
Strahlenther Onkol; 2020 May; 196(5):457-464. PubMed ID: 32016497
[TBL] [Abstract][Full Text] [Related]
16. Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients.
Kim MS; Lim J; Shin HS; Cho KG
Brain Tumor Res Treat; 2020 Apr; 8(1):29-35. PubMed ID: 32390351
[TBL] [Abstract][Full Text] [Related]
17. The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma.
Chan J; Jayamanne D; Wheeler H; Khasraw M; Wong M; Kastelan M; Guo L; Back M
Clin Transl Radiat Oncol; 2020 May; 22():33-39. PubMed ID: 32195378
[TBL] [Abstract][Full Text] [Related]
18. Re-Irradiation for Recurrent Glioblastoma Multiforme.
Rades D; Witteler J; Leppert J; Schild SE
Anticancer Res; 2020 Dec; 40(12):7077-7081. PubMed ID: 33288605
[TBL] [Abstract][Full Text] [Related]
19. Impact of Reirradiation Utilizing Fractionated Stereotactic Radiotherapy for Recurrent Glioblastoma.
Shields LB; O'Dell P; Daniels MW; Sevak PR; Highfield HA; Sinicrope KD; Sun DA; Spalding AC
Cureus; 2024 Jan; 16(1):e53001. PubMed ID: 38406061
[TBL] [Abstract][Full Text] [Related]
20. Brain Re-Irradiation Robustly Accounting for Previously Delivered Dose.
Thompson C; Pagett C; Lilley J; Svensson S; Eriksson K; Bokrantz R; Ödén J; Nix M; Murray L; Appelt A
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
